REX AI Equity Premium Income ETF vs Novartis AG — how do they compare? REX AI Equity Premium Income ETF trades at $37.3, while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG pays a 3.07% dividend while REX AI Equity Premium Income ETF pays none, and Novartis AG is trading nearer its 52-week high, REX AI Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| AIPI | NVS | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $44.93 | $168.62 |
52-Week Low | $32.45 | $119.31 |
Market Cap | — | $295.37B |
Enterprise Value | — | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Read more on AIPI →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →